Drug Side Effects
Search
MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA
MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA
was reported 54 times
MYELODYSPLASTIC SYNDROME WITH SINGLE LINEAGE DYSPLASIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
10
0.0004
1
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
2
0.0001
2
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
1
0.0001
3
Topoisomerase Inhibitor [EPC]
4
0.0001
4
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
1
0.0000
5
Erythropoiesis-stimulating Agent [EPC]
2
0.0000
6
Provitamin D2 Compound [EPC]
1
0.0000
7
Purine Antimetabolite [EPC]
3
0.0000
8
Complement Inhibitor [EPC]
1
0.0000
9
BCL-2 Inhibitor [EPC]
1
0.0000
10
Nitroimidazole Antimicrobial [EPC]
1
0.0000
11
Platinum-based Drug [EPC]
4
0.0000
12
Corticosteroid [EPC]
18
0.0000
13
CD20-directed Cytolytic Antibody [EPC]
4
0.0000
14
Folate Analog Metabolic Inhibitor [EPC]
5
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
3
0.0000
16
Interleukin-23 Antagonist [EPC]
1
0.0000
17
Kinase Inhibitor [EPC]
5
0.0000
18
alpha-Adrenergic Blocker [EPC]
1
0.0000
19
Leukocyte Growth Factor [EPC]
1
0.0000
20
Janus Kinase Inhibitor [EPC]
1
0.0000
21
Vitamin B12 [EPC]
2
0.0000
22
Microtubule Inhibitor [EPC]
1
0.0000
23
Loop Diuretic [EPC]
2
0.0000
24
Opioid Agonist [EPC]
1
0.0000
25
Platelet Aggregation Inhibitor [EPC]
2
0.0000
26
Vitamin D [EPC]
1
0.0000
27
beta-Adrenergic Blocker [EPC]
1
0.0000
28
Vitamin C [EPC]
1
0.0000
29
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
30
Tumor Necrosis Factor Blocker [EPC]
2
0.0000